GLP-1/GIP + B12 Microdose

*Actual vial appearance, contents, and dosage may vary and is based on your prescription.

GLP-1/GIP + B12 Microdose

GLP-1/GIP + B12 Microdose is a provider-guided option designed for patients seeking a lower-dose approach to metabolic wellness, appetite support, and weight-management care. This dual-incretin therapy targets both GLP-1 and GIP pathways involved in hunger signaling, glucose regulation, and gastric emptying, while added B12 supports normal energy metabolism. The microdose format offers a more gradual approach that may be appropriate based on individual goals, tolerance, and provider evaluation.
Free Shipping
Medical Consultation Included
  • Available in 48 states, excluding Alabama and Mississippi.
  • No hidden membership, consultation, or shipping costs
  • Care reviewed by a licensed provider in your state
  • Prescription issued only when clinically appropriate

Appetite Control
Appetite Control
Metabolic Balance
Metabolic Balance
Gradual Weight Support
Gradual Weight Support

Supports Appetite Control

GLP-1/GIP therapy may help support appetite regulation and feelings of fullness, making it easier to maintain healthy eating habits and portion control.

Supports Healthy Weight Management

By acting on GLP-1 and GIP pathways involved in appetite and metabolism, microdose therapy may support healthy weight-management goals when combined with appropriate nutrition and lifestyle habits.

Supports Blood Sugar Regulation

GLP-1 and GIP signaling play important roles in glucose-dependent insulin response and overall metabolic function, helping support healthy blood sugar regulation.

Supports Metabolic Wellness

This therapy may help support several metabolic pathways involved in appetite, glucose handling, and energy balance, promoting overall metabolic wellness.

Supports Energy & Nutritional Wellness

Vitamin B12 supports normal energy metabolism, red blood cell formation, and nervous-system function, complementing a comprehensive weight-management and wellness program.

  • Initial 3-month care period
  • Designed to support continuity, monitoring, and consistency of care
  • Ongoing care options available following the initial period, with the ability to manage or discontinue thereafter

  • Clinical review typically completed within 24 hours
  • Pharmacy processing may take 2–7 business days, depending on availability
  • Once dispensed, medication is shipped via 2-day delivery

Your Celara Med plan also includes access to our wellness app with
workouts, recipes, meal plans, nutrition guidance, habit tracking, and progress tools
to help support your overall health goals.

Celara Med Wellness App

  • Personalized Workouts
  • Recipes & Meal Plans
  • Nutrition & Macro Tracking
  • Progress & Habit Tracking

Prescriptions are issued by licensed healthcare providers based on an individual clinical evaluation and medical eligibility. Compounded medications are not FDA-approved, and their safety and effectiveness have not been independently evaluated by the FDA.

This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.


Important Note:

Information provided is for educational purposes only and does not constitute medical advice. All care and prescriptions are provided solely at the discretion of a licensed healthcare provider following an individual evaluation.

Scientific Sources

Developed with reference to established scientific understanding of its components.

Our Community

Real people, real results. Here’s what our patients have to say about their experience with Celara Med.

frequently asked questions

Quick answers to common questions, designed to help you feel clear and confident as you explore Celara Med.

GLP-1/GIP therapy works through two metabolic hormone pathways involved in appetite, blood-sugar regulation, digestion, and energy balance. The microdose approach uses a lower, individualized amount selected by the prescribing provider, with B12 included in the compounded formulation when clinically appropriate.

Depending on the individual treatment plan, therapy may support appetite control, portion awareness, metabolic health, and weight-management goals. A microdose approach may be considered for patients whose provider determines that a lower-dose strategy is appropriate.

Microdosing allows the provider to take a more individualized approach rather than automatically using standard commercial dose strengths. It may be considered for patients who are beginning therapy, pursuing more gradual treatment, or who need a customized dose based on their clinical needs. Compounded dosing should be individualized by the prescriber.

Vitamin B12 plays an important role in normal energy metabolism, red-blood-cell formation, and nervous-system function. When included in a compounded GLP-1/GIP formulation, it is an additional ingredient rather than the component responsible for the medication’s GLP-1/GIP effects.

Adults interested in provider-guided support for weight management, appetite control, or metabolic wellness may be evaluated. Eligibility and dosing are determined by a licensed provider based on your medical history, medications, previous treatment experience, and individual goals.

As with GLP-1/GIP therapy, some people may experience temporary digestive changes such as nausea, decreased appetite, constipation, diarrhea, or stomach discomfort, particularly as the body adjusts. Your provider will review what to expect and help determine an appropriate treatment approach for you.